AIM ImmunoTech AIM
NYSE AIM
$0.18 +0.01 (+3.94%)
As of: Sep 30, 2026 · 9:43 AM EDT

AIM ImmunoTech (AIM) Other financing activities (2017 - 2018)

Updated

AIM ImmunoTech's Other financing activities came in at -$59,000 for Q4 2018, compared with $12,000 a year earlier.

Analysis

AIM ImmunoTech (AIM) Other financing activities (2017 - 2018) Analysis & Trends

For FY2018, AIM ImmunoTech's Other financing activities was $439,000, up 330.4% from FY2017.

  • Going back by year, Other financing activities was $102,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 AIM ImmunoTech 3.08 Mn -18.22 Mn 21,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -59,000.00
Sep 30, 2018 230,000.00
Mar 31, 2018 268,000.00
Dec 31, 2017 12,000.00
Sep 30, 2017 1,000.00
API Access

AIM ImmunoTech Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AIM&period=max&api_key=YOUR_API_KEY